Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian G Wicha

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Pharmaceutics|July 27, 2022
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with RifampicinLina Keutzer, Huifang You, Ali Farnoud, et al.
The Lancet. Microbe|July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient careZackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
Intensive Care Medicine|July 13, 2023
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecastingSebastian Greppmair, Alexander Brinkmann, Anka Roehr, et al.
Frontiers in Pharmacology|February 5, 2024
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centersHélène Thirot, David Fage, Antonia Leonhardt, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 11, 2025
Towards model-informed precision dosing of intravenous linezolid: a multicentre external evaluation of pharmacokinetic models in critically ill adultsJohannes Starp, Antonia Leonhardt, Michael Zoller, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Intensive Care Medicine|May 9, 2020
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper<sub>.</sub>Mohd H Abdul-Aziz, Jan-Willem C Alffenaar, Matteo Bassetti, et al.
Nature Communications|September 3, 2024
Towards clinically relevant dose ratios for Cabamiquine and Pyronaridine combination using P. falciparum field isolate dataMohamed Maiga, Laurent Dembele, Perrine Courlet, et al.
Tuberculosis (Edinburgh, Scotland)|February 13, 2026
Towards model-informed precision dosing of clofazimine, moxifloxacin, and terizidone/cycloserine in the treatment of drug-resistant tuberculosis: An external model evaluation studyEmily Behrens, Niklas Köhler, Max Münchow, et al.
Pharmaceutics|November 25, 2023
A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant TuberculosisNiklas Köhler, Hande Karaköse, Hans-Peter Grobbel, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Pharmaceutics|July 27, 2022
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with RifampicinLina Keutzer, Huifang You, Ali Farnoud, et al.
The Lancet. Microbe|July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient careZackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
Intensive Care Medicine|July 13, 2023
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecastingSebastian Greppmair, Alexander Brinkmann, Anka Roehr, et al.
Frontiers in Pharmacology|February 5, 2024
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centersHélène Thirot, David Fage, Antonia Leonhardt, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 11, 2025
Towards model-informed precision dosing of intravenous linezolid: a multicentre external evaluation of pharmacokinetic models in critically ill adultsJohannes Starp, Antonia Leonhardt, Michael Zoller, et al.
Therapeutic Drug Monitoring|April 22, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyDahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, et al.
Intensive Care Medicine|May 9, 2020
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper<sub>.</sub>Mohd H Abdul-Aziz, Jan-Willem C Alffenaar, Matteo Bassetti, et al.
Nature Communications|September 3, 2024
Towards clinically relevant dose ratios for Cabamiquine and Pyronaridine combination using P. falciparum field isolate dataMohamed Maiga, Laurent Dembele, Perrine Courlet, et al.
Tuberculosis (Edinburgh, Scotland)|February 13, 2026
Towards model-informed precision dosing of clofazimine, moxifloxacin, and terizidone/cycloserine in the treatment of drug-resistant tuberculosis: An external model evaluation studyEmily Behrens, Niklas Köhler, Max Münchow, et al.
Pharmaceutics|November 25, 2023
A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant TuberculosisNiklas Köhler, Hande Karaköse, Hans-Peter Grobbel, et al.
Pageof 12